1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TMED7-TICAM2 CTRPv2 pan-cancer AAC -0.1 0.01
mRNA TSPAN6 CTRPv2 pan-cancer AAC 0.1 0.01
mRNA TTC27 CTRPv2 pan-cancer AAC -0.092 0.01
mRNA BLK CTRPv2 pan-cancer AAC -0.098 0.01
mRNA EEPD1 CTRPv2 pan-cancer AAC 0.092 0.01
mRNA GPR55 CTRPv2 pan-cancer AAC 0.09 0.01
mRNA MAGEA9 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA CALML4 CTRPv2 pan-cancer AAC 0.093 0.01
mRNA MPST CTRPv2 pan-cancer AAC 0.093 0.01
mRNA CA13 CTRPv2 pan-cancer AAC 0.094 0.01
Download CSV